tradingkey.logo
tradingkey.logo
Search

Vivani Medical Provides Update On Clinical Development Plans For Npm-139 Semaglutide Implant For Chronic Weight Management

ReutersSep 4, 2025 3:27 PM
facebooktwitterlinkedin

Vivani Medical Inc VANI.O:

  • VIVANI MEDICAL PROVIDES UPDATE ON CLINICAL DEVELOPMENT PLANS FOR NPM-139 SEMAGLUTIDE IMPLANT FOR CHRONIC WEIGHT MANAGEMENT

  • VIVANI MEDICAL INC - TO INITIATE PHASE 1 STUDY FOR NPM-139 IN 2026

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Recommended Articles

Tradingkey
KeyAI